Months 6 and beyond For those who stick with GLP-1 medications long-term, weight loss of 10% to 15% is common
9 Detailed Analysis of the Violation The "Excel" Problem: The inspection found that "Excel worksheets used to perform chromatogram calculations were not retained" and "several recent Excel spreadsheets used to perform suitability and assay calculations were deleted".9 Excel is a powerful tool, but in a CGMP environment, it is considered "software" that requires validation
It can be used with all skin condition
These symptoms may indicate serious conditions such as pancreatitis, gallbladder disease, or dehydration leading to acute kidney injury, which have been associated with the GLP-1 receptor agonist class and require prompt clinical review
Tirzepatide: The New Contender Tirzepatide is a newer medication that acts on both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, making it a dual agonist
One of its main roles lies in stimulating hair follicles and promoting hair growth